Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1

Conditions

Bone Neoplasms 3Spinal Cord Compression 1Paraproteinemias 1Osteosarcoma 1Neoplastic Processes 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Hematologic Neoplasms 1Hematologic Diseases 1Giant Cell Tumors 1Giant Cell Tumor of Bone 1Fractures, Bone 1Bone Marrow Diseases 1Bone Diseases 1Blood Protein Disorders 1

Interventions

Cyclophosphamide 28Busulfan 17Antilymphocyte Serum 17fludarabine phosphate 16Filgrastim 16Radiotherapy 15Peripheral Blood Stem Cell Transplantation 15Cyclosporine 15Mycophenolic Acid 13Tacrolimus 12Methotrexate 11Methylprednisolone 10Cord Blood Stem Cell Transplantation 9Melphalan 8Etoposide 8Whole-Body Irradiation 6Thiotepa 4Cytarabine 3Carmustine 3sargramostim 2aldesleukin 2Sirolimus 2Granulocyte Colony-Stimulating Factor 2Carboplatin 2resiquimod 1poly ICLC 1Zoledronic Acid 1Voriconazole 1Vancomycin 1Transplantation, Homologous 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Denosumab × Sarcoma × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡